Solène Savrimoutou

571 total citations
25 papers, 421 citations indexed

About

Solène Savrimoutou is a scholar working on Organic Chemistry, Molecular Biology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Solène Savrimoutou has authored 25 papers receiving a total of 421 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Organic Chemistry, 11 papers in Molecular Biology and 6 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Solène Savrimoutou's work include Synthesis and Biological Evaluation (14 papers), Cancer therapeutics and mechanisms (6 papers) and Synthesis and biological activity (6 papers). Solène Savrimoutou is often cited by papers focused on Synthesis and Biological Evaluation (14 papers), Cancer therapeutics and mechanisms (6 papers) and Synthesis and biological activity (6 papers). Solène Savrimoutou collaborates with scholars based in France, Italy and Czechia. Solène Savrimoutou's co-authors include Stéphane Moreau, Jean Guillon, Luisa Ronga, Mathieu Marchivie, Pascal Sonnet, Noël Pinaud, Vanessa Desplat, Nadine Azas, Anita Cohen and Catherine Mullié and has published in prestigious journals such as Nucleic Acids Research, SHILAP Revista de lepidopterología and RSC Advances.

In The Last Decade

Solène Savrimoutou

22 papers receiving 416 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Solène Savrimoutou France 10 306 127 45 28 20 25 421
Garreth L. Morgans South Africa 11 397 1.3× 152 1.2× 47 1.0× 32 1.1× 25 1.3× 21 455
Nicolas Primas France 12 297 1.0× 99 0.8× 73 1.6× 27 1.0× 19 0.9× 42 382
Eleonora Elhalem Argentina 10 271 0.9× 116 0.9× 37 0.8× 55 2.0× 10 0.5× 13 370
Stéphanie Vandekerckhove Belgium 9 350 1.1× 90 0.7× 47 1.0× 13 0.5× 32 1.6× 9 422
Ana M. Bruno Argentina 12 310 1.0× 127 1.0× 26 0.6× 40 1.4× 16 0.8× 27 408
Gloria Serra Uruguay 13 400 1.3× 203 1.6× 46 1.0× 36 1.3× 10 0.5× 37 516
Parameshwar Makam India 12 459 1.5× 126 1.0× 29 0.6× 20 0.7× 36 1.8× 21 577
Shuren Zhu United States 10 327 1.1× 193 1.5× 64 1.4× 24 0.9× 25 1.3× 11 461
Anita Cohen France 12 334 1.1× 74 0.6× 119 2.6× 72 2.6× 23 1.1× 26 427
Zhong‐Ke Yao China 10 220 0.7× 133 1.0× 48 1.1× 14 0.5× 15 0.8× 14 395

Countries citing papers authored by Solène Savrimoutou

Since Specialization
Citations

This map shows the geographic impact of Solène Savrimoutou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Solène Savrimoutou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Solène Savrimoutou more than expected).

Fields of papers citing papers by Solène Savrimoutou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Solène Savrimoutou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Solène Savrimoutou. The network helps show where Solène Savrimoutou may publish in the future.

Co-authorship network of co-authors of Solène Savrimoutou

This figure shows the co-authorship network connecting the top 25 collaborators of Solène Savrimoutou. A scholar is included among the top collaborators of Solène Savrimoutou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Solène Savrimoutou. Solène Savrimoutou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Guillon, Jean, Solène Savrimoutou, Olivier Helynck, et al.. (2025). Design, synthesis, biophysical and biological evaluation of original condensed pyrrolopyrimidine and pyrrolopyridine ligands as anti-SARS-CoV-2 agents targeting G4. European Journal of Medicinal Chemistry. 292. 117655–117655.
2.
Guillon, Jean, Patrice Agnamey, Céline Damiani, et al.. (2024). Design, Synthesis, and In Vitro Antimalarial Evaluation of New 1,3,5-Tris[(4-(Substituted-Aminomethyl)Phenoxy)Methyl]Benzenes. SHILAP Revista de lepidopterología. 3(3). 615–637. 2 indexed citations
3.
Das, Rabindra Nath, Anita Cohen, Solène Savrimoutou, et al.. (2023). Development, Synthesis and Antiprotozoal Assessment of New Substituted Diquinolinyl-Pyridine Derivatives as Antiparasitic Agents by Potential G-4 Binding. Acta Scientific Pharmaceutical Sciences. 7(7). 15–33.
4.
Guillon, Jean, Anita Cohen, Patrice Agnamey, et al.. (2023). Synthesis and Antimalarial Evaluation of New 1,3,5-tris[(4-(Substituted-aminomethyl)phenyl)methyl]benzene Derivatives: A Novel Alternative Antiparasitic Scaffold. SHILAP Revista de lepidopterología. 2(3). 653–672. 3 indexed citations
5.
Guillon, Jean, Solène Savrimoutou, Noël Pinaud, et al.. (2023). Synthesis, Crystal Structure and Anti-Leukemic Activity of (E)-Pyrrolo[1,2-a]quinoxalin-4-yl)-1-(3,4,5-trimethoxyphenyl)prop-2-en-1-one. SHILAP Revista de lepidopterología. 2023(3). M1691–M1691. 1 indexed citations
6.
Guillon, Jean, et al.. (2022). Synthesis, Crystal Structure and Anti-Leukemic Activity of 1,3-Dihydro-1-{1-[4-(4-phenylpyrrolo[1,2-a]quinoxalin-3-yl)benzyl]piperidin-4-yl}-2H-benzimidazol-2-one. SHILAP Revista de lepidopterología. 2022(1). M1333–M1333. 6 indexed citations
7.
Guillon, Jean, Noël Pinaud, Solène Savrimoutou, et al.. (2021). Crystal Structure of 1-(3-Ferrocenyl-2-methylpyrrolo[1,2-<i>a</i>]quinoxalin-4-yl)piperazin-4-ium Chloride. X-ray Structure Analysis Online. 37(0). 65–67. 1 indexed citations
8.
Guillon, Jean, Caroline Denevault‐Sabourin, Edith Chevret, et al.. (2021). Design, synthesis, and antiproliferative effect of 2,9‐bis[4‐(pyridinylalkylaminomethyl)phenyl]‐1,10‐phenanthroline derivatives on human leukemic cells by targeting G‐quadruplex. Archiv der Pharmazie. 354(8). e2000450–e2000450. 6 indexed citations
9.
Guillon, Jean, Stéphane Moreau, Luisa Ronga, et al.. (2020). Synthesis of new piperazinyl-pyrrolo[1,2-a]quinoxaline derivatives as inhibitors of Candida albicans multidrug transporters by a Buchwald–Hartwig cross-coupling reaction. RSC Advances. 10(5). 2915–2931. 13 indexed citations
10.
Guillon, Jean, Solène Savrimoutou, Stéphane Moreau, et al.. (2020). 1-Phenyl-8-[[4-(pyrrolo[1,2-a]quinoxalin-4-yl)phenyl]methyl]-1,3,8-triazaspiro[4.5]decan-4-one: Synthesis, Crystal Structure and Anti-Leukemic Activity. SHILAP Revista de lepidopterología. 2020(1). M1113–M1113. 7 indexed citations
11.
Guillon, Jean, Solène Savrimoutou, François Hallé, et al.. (2018). Crystal structure and identification of a pyrimido[6,1-b][1,3]oxazin-6-one derivative from the reaction of acrolein with 5-(phenoxymethyl)-2-amino-2-oxazoline. Comptes Rendus Chimie. 21(11). 987–992. 1 indexed citations
12.
Desplat, Vanessa, Romain Lucas, Stéphane Moreau, et al.. (2017). Synthesis and Antiproliferative Effect of Ethyl 4‐[4‐(4‐Substituted Piperidin‐1‐yl)]benzylpyrrolo[1,2‐a]quinoxalinecarboxylate Derivatives on Human Leukemia Cells. ChemMedChem. 12(12). 940–953. 35 indexed citations
13.
Cohen, Anita, Rabindra Nath Das, Stéphane Moreau, et al.. (2017). Design, synthesis and antimalarial activity of novel bis{N-[(pyrrolo[1,2-a]quinoxalin-4-yl)benzyl]-3-aminopropyl}amine derivatives. Journal of Enzyme Inhibition and Medicinal Chemistry. 32(1). 547–563. 59 indexed citations
14.
Guillon, Jean, Anita Cohen, Rabindra Nath Das, et al.. (2017). Design, synthesis, and antiprotozoal evaluation of new 2,9‐bis[(substituted‐aminomethyl)phenyl]‐1,10‐phenanthroline derivatives. Chemical Biology & Drug Design. 91(5). 974–995. 22 indexed citations
15.
Moreau, Stéphane, Luisa Ronga, Rabindra Nath Das, et al.. (2016). Design, Synthesis, and Evaluation of 2,9‐Bis[(substituted‐aminomethyl)phenyl]‐1,10‐phenanthroline Derivatives as G‐Quadruplex Ligands. ChemMedChem. 12(2). 146–160. 20 indexed citations
16.
Desplat, Vanessa, Romain Lucas, Stéphane Moreau, et al.. (2016). Synthesis and evaluation of the cytotoxic activity of novel ethyl 4-[4-(4-substitutedpiperidin-1-yl)]benzyl-phenylpyrrolo[1,2-a]quinoxaline-carboxylate derivatives in myeloid and lymphoid leukemia cell lines. European Journal of Medicinal Chemistry. 113. 214–227. 38 indexed citations
17.
Moreau, Stéphane, Luisa Ronga, Anita Cohen, et al.. (2016). Design, Synthesis and Antimalarial Activity of Some New Aminoalcoholpyrrolo[1,2-a]quinoxaline Derivatives. Letters in Drug Design & Discovery. 13(9). 932–942. 9 indexed citations
18.
Ronga, Luisa, Anita Cohen, Patrice Le Pape, et al.. (2014). Design, synthesis and biological evaluation of novel 4-alkapolyenylpyrrolo[1,2-a]quinoxalines as antileishmanial agents – Part III. European Journal of Medicinal Chemistry. 81. 378–393. 47 indexed citations
19.
Guillon, Jean, Marc Le Borgne, Charlotte Rimbault, et al.. (2013). Synthesis and biological evaluation of novel substituted pyrrolo[1,2-a]quinoxaline derivatives as inhibitors of the human protein kinase CK2. European Journal of Medicinal Chemistry. 65. 205–222. 94 indexed citations
20.
Moreau, Stéphane, Vanessa Desplat, Solène Savrimoutou, et al.. (2012). Crystal structure of [2]benzopyrano[3,4-b]quinoxalin-5-one through spontaneous air oxidation rearrangement of 6-Chloro-isoindolo[2,1-a]quinoxaline. Comptes Rendus Chimie. 15(9). 753–757.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026